Related Experiment Video
Updated: Feb 22, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
The Cks1/Cks2 axis fine-tunes Mll1 expression and is crucial for MLL-rearranged leukaemia cell viability
William Grey1, Adam Ivey1, Thomas A Milne2
1Department of Medical and Molecular Genetics, King's College London, Faculty of Life Sciences and Medicine, London, UK.
Abstract:
The Cdc28 protein kinase subunits, Cks1 and Cks2, play dual roles in Cdk-substrate specificity and Cdk-independent protein degradation, in concert with the E3 ubiquitin ligase complexes SCFSkp2 and APCCdc20. Notable targets controlled by Cks include p27 and Cyclin A. Here, we demonstrate that Cks1 and Cks2 proteins interact with both the MllN and MllC subunits of Mll1 (Mixed-lineage leukaemia 1), and together, the Cks proteins define Mll1 levels throughout the cell cycle. Overexpression of CKS1B and CKS2 is observed in multiple human cancers, including various MLL-rearranged (MLLr) AML subtypes. To explore the importance of MLL-Fusion Protein regulation by CKS1/2, we used small molecule inhibitors (MLN4924 and C1) to modulate their protein degradation functions. These inhibitors specifically reduced the proliferation of MLLr cell lines compared to primary controls. Altogether, this study uncovers a novel regulatory pathway for MLL1, which may open a new therapeutic approach to MLLr leukaemia.
Insights
Cks1 and Cks2 proteins regulate MLL1 levels, impacting cell cycle and cancer. Inhibiting Cks1/2 reduced proliferation in MLL-rearranged leukemia cell lines, suggesting a new therapeutic target.
Area of Science:
- Molecular Biology
- Cell Biology
- Cancer Research
Background:
- Cdc28-associated proteins Cks1 and Cks2 regulate cyclin-dependent kinase (Cdk) substrate specificity and protein degradation.
- These proteins interact with E3 ubiquitin ligase complexes SCFSkp2 and APCCdc20, targeting proteins like p27 and Cyclin A.
- Overexpression of CKS1B and CKS2 is linked to various human cancers, including MLL-rearranged (MLLr) acute myeloid leukemia (AML).
Purpose of the Study:
- To investigate the interaction between Cks1/Cks2 and Mixed-lineage leukemia 1 (MLL1) protein.
- To determine the role of Cks1 and Cks2 in regulating MLL1 levels throughout the cell cycle.
- To explore the therapeutic potential of targeting Cks1/Cks2 in MLLr leukemia.
Main Methods:
- Co-immunoprecipitation assays to confirm Cks1/Cks2 interaction with MLL1 subunits (MllN and MllC).
- Cell cycle analysis to assess MLL1 level regulation by Cks proteins.
- Treatment of MLLr cell lines with small molecule inhibitors (MLN4924 and C1) targeting protein degradation pathways.
Main Results:
- Cks1 and Cks2 directly interact with both MllN and MllC subunits of MLL1.
- Cks proteins are crucial for defining MLL1 protein levels across the cell cycle.
- Inhibition of Cks1/Cks2-mediated protein degradation significantly reduced proliferation in MLLr cell lines compared to controls.
Conclusions:
- Cks1 and Cks2 establish a novel regulatory pathway for MLL1.
- This Cks-MLL1 interaction presents a potential therapeutic strategy for MLLr leukemia.
- Targeting Cks proteins may offer a new avenue for treating MLLr leukemias.
Related Concept Videos
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Inhibition of Cdk Activity
Abnormal Proliferation
Positive Regulator Molecules
Mitogens and the Cell Cycle
Anaphase Promoting Complex

